Sweden Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Sweden Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report “Sweden Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Sweden. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Swedish pharmaceutical market, in terms of US dollars, was valued at $4.8 billion in 2015, which increased at a compound annual growth rate (CAGR) of 4.4% to $6.2 billion in 2021. In terms of the Swedish krona (SEK), it was valued at SEK40.6 billion in 2015, which increased at a CAGR of 4.7% to SEK53.4 billion in 2021. The market value is expected to reach $7.8 billion in 2026 in terms of US dollars and is estimated to reach SEK67.3 by 2026. This difference is primarily due to currency exchange fluctuations. In 2016, the medical devices market in Sweden was worth $1.7 billion, which increased at a CAGR of 3.7% to $2.1 billion in 2021. The medical device market is expected to grow at a CAGR of 3.7% from 2022 to reach $2.4 billion in 2027. Sweden has a robust healthcare system with universal healthcare coverage. Government initiatives such as Vision for eHealth 2025 and National Approach to Artificial Intelligence (AI) aim to encourage the adoption of digital health solutions. The comprehensive healthcare system in Sweden provides favorable market access circumstances for innovative pharmaceuticals. However, the displacement of generics and price decreases limit the expansion of the pharmaceutical business.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Sweden, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
• Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Sanofi, Novartis, GlaxoSmithKline (GSK), and Sobi.
• Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Stryker, Alcon, and Getinge.
• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
• An overview of the opportunities for and challenges to growth in the Sweden healthcare market

• Develop business strategies by understanding the trends shaping and driving the Indonesian healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Indonesian healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership